DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Young G, Sidonio RF, Liesner R. , et al.
HAVEN 2 updated analysis: multicenter, open-label, phase 3 study to evaluate efficacy, safety and pharmacokinetics of subcutaneous administration of emicizumab prophylaxis in pediatric patients with hemophilia A with inhibitors.
Blood 2017;
130: 85
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.